Research Institute Of Geroprotective Technologies

This study tests an inhaled medicine called Aroxxen to see if it can reduce heart damage during and after a common procedure to open blocked heart arteries (stent placement). About 180 adults with coronary artery disease will receive either Aroxxen or standard care. Researchers w…